Avricore Health Inc (AVCRF)

[wingtrade]

Vanc Pharma hires Transcend for IR services

2018-08-23 16:42 ET - News Release


Mr. Bob Rai reports

Vanc Pharmaceuticals Inc. has entered into a consulting agreement with Transcend Capital Inc. to develop and implement an investor relations program for the company. Transcend, with offices in Vancouver, B.C., is a full-service investor relations firm that assists small and mid-cap public companies with market awareness campaigns, and helps these companies gain valued industry exposure through an extensive network of retail and institutional clients. Etienne Moshevich is the sole owner of Transcend.

Transcend will provide comprehensive investor relations services to the company for an initial period of 24 months for an aggregate fee of $150,000 plus applicable taxes. Transcend and its directors, officers and employees are shareholders of the company, collectively holding approximately 3.5 per cent of the issued and outstanding common shares of the company.

The investor relations consulting agreement is subject to the approval of the TSX Venture Exchange.

About Vanc Pharmaceuticals Inc.

Vanc Pharmaceuticals aims to become the partner of choice for forward-thinking pharmacies across Canada. With an established sales force, distribution network, and team of highly experienced professionals in pharmacy, point-of-care testing and health technology, Vanc is growing beyond generics to provide pharmacists with innovative, value-added products and services to expand their scope of practice and support their evolving role as front-line healthcare providers.

We seek Safe Harbor.

© 2018 Canjex Publishing Ltd. All rights reserved.
https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aVANC-2650215&symbol=VANC®ion=C